Some call us Arabs, some call us Africans, and some call us Afro-arab... Being Sudanese is not about ethnicity, it's all about the values that we embrace, love we share, ethics and values embroided to our souls. #SudanProtests #SudanUprising #السودان – at Khartoum, Sudan

Presented at #IGCS2026: Our structured needs assessment on Gynecologic Oncology capacity in Sudan post-armed conflict (14 facilities across 10 states): • Brachytherapy unavailable across all surveyed sites • Radiation wait times >5–8 weeks where referrals exist • Screening absent in 79% of centers Internally displaced persons comprise up to 50% of the patient volume at receiving peripheral centers, alongside severe deficits in surgical oncology workforce and basic palliative care (oral morphine). Targeted global oncology support is urgent. ​📚 shorturl.at/RE7To @IGCSociety

How should we govern AI in health professions education? 1/5 AI in health professions education is not just a technology question. It is a question of governance, ethics, academic integrity, equity and professional identity. Our critical narrative review examines these challenges. 📄 shorturl.at/V450L 2/5 First: governance. Institutional responses may be fragmented, while educational applications of AI continue to evolve. How can policies remain useful without becoming quickly outdated? 3/5 Second: ethics. AI raises difficult questions about autonomy, beneficence, non-maleficence and justice—particularly when systems are opaque or data-driven. 4/5 Third and fourth: generative AI challenges established ideas of authorship and academic integrity, while bias and unequal access raise concerns about equity and professional development. 5/5 Responsible AI in medical education needs more than a blanket “allow” or “ban.” Our review proposes a risk-based governance taxonomy. What should institutions prioritise first: transparency, assessment integrity, fairness or accountability? #MedicalEducation #AIethics

⚖️Should AI in medical education be banned, permitted, or governed according to risk? 📰Our new critical narrative review examines the ethical and regulatory challenges of AI in Health Professions Education. 📚452 records → 34 included sources → 4 major themes → a proposed risk-based governance taxonomy. 💡The question may no longer be simply whether AI belongs in medical education, but how different AI applications should be governed according to their educational risk. 📖 J Adv Med Educ Prof. 2026;14(4):307–319 DOI: 10.30476/jamp.2026.110257.2340 shorturl.at/xrag2 #AI #MedEd #MedicalEducation #AIgovernance

🧬 Can molecular profiling help us understand survival after liver-directed therapy in metastatic uveal melanoma? Our abstract in ESMO Open explores the impact of tumour biology on outcomes following chemosaturation with percutaneous hepatic perfusion (CS-PHP). In our cohort of 12 patients, exploratory molecular analysis found that: 🔹 BAP1 loss/mutation was associated with shorter overall survival 🔹 Monosomy 3 was also associated with less favourable outcomes These findings suggest that molecular features may provide important prognostic information beyond clinical treatment outcomes and could potentially help refine patient selection and treatment strategies. The study also reports an ORR of 66.7%, median hepatic PFS of 18.4 months and median OS of 28 months, with no treatment-related fatalities. While these molecular findings require validation in larger prospective cohorts, they highlight the importance of integrating tumour biology with liver-directed treatment in metastatic uveal melanoma. 📄 Read our study in ESMO Open: shorturl.at/Z6ald

Guidelines still disagree on how long to taper steroids after ICI-myocarditis. ESC favours 17–20 weeks to reduce recurrence, SITC/ASCO/NCCN favour 4–6 weeks to limit infection, metabolic and CV toxicity. Convert IV to oral prednisone ~1 mg/kg (max 80 mg) once troponin has fallen >50% & the patient is electrically and haemodynamically stable. Then individualise the taper to troponin normalisation—not a fixed calendar. #CardioOnc #CardioOncology #ICI #Myocarditis #irAE #Immunotherapy rdcu.be/4ExuHmNDiGna

Landmark, practice-changing data at @IASLC #WCLC26! 🚨 The Phase 3 MAVERIC trial compared PCI vs MRI surveillance in SCLC (~68% LS, 32% ES). ➡️MRI surveillance improved cognitive failure-free survival (CFFS) with NO detriment to OS, avoiding the significant G3+ toxicity of the PCI arm. While PCI decreased brain mets, PFS was unchanged. In the MRI era, PCI has no clear role in either LS- or ES-SCLC management. RIP PCI! 🪦👋